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Constant formation of free radicals mainly reactive oxygen
species (ROS) is the main characteristic of all living systems
which use oxygen for their basal metabolism. Primarily, ROS
are considered an integral component of basic cell regulation
and signaling pathways certainly, suppressing tumor progres-
sion which forms the basis of themost chemotherapeutic and
radiotherapeutic agents.Themost commonROS are superox-
ide radical (O
2
⋅−) and hydrogen peroxide (H
2
O
2
) which can
stimulate consecutive reactions leading to further production
of free radicals and related oxidative damage to cellular
compartments. On the other side, there are several antioxi-
dant complexes which defend cellular integrity against free
radical-induced damages by neutralizing oxidative elements.
Superoxide dismutase is the main antioxidant enzyme which
converts O
2
⋅− to H
2
O
2
and then the other enzyme located in
peroxisomes, catalase, disposes of H
2
O
2
by converting it to
O
2
and H
2
O. Keeping the balance of such cell homeostasis
in a level at which ROS are not able to damage cells is vital.
Excessive ROS not only cause damage toward cellular lipids
and DNA but also participate in posttranslational dysfunc-
tion of proteins or enzymes involved in keeping viability
and function of the cells [1, 2]. Accordingly, oxidative stress
and the accompanying pathway, inflammation, are known to
be involved in the pathology of numerous human diseases
including cancer, neurodegenerative diseases, rheumatoid
arthritis, and diabetes. As an example, oxidative and inflam-
matory mechanisms were considered for neurodegenerative
diseases primarily when it was observed that using high
amounts of anti-inflammatory drugs in rheumatoid arthritis
patients for long times was associated with less incidence of
Alzheimer’s disease (AD). However, there are many factors
affecting the rate of ROS formation in the body among which
lifestyle related habits like diet, cigarette smoking, alcohol
consumption, environmental exposures, and stress are the
most important. Apart from all these factors, it is evident
that ROS and the other free radicals are more produced
and accumulated in the body over time. This has led to a
hypothesis on the implication of oxidative stress in aging and
inspired researchers to find new therapies for battling age-
related diseases through exploiting agents which modulate
oxidant/antioxidant homeostasis [1, 2]. This special issue
is composed of articles focused on describing the seminal
research and viewpoints pertinent to current understanding
of the role of oxidative stress in aging and perspectives on
treatment of age-related diseases.
In this special issue, the comparative effects of biodynes,
tocotrienol-rich fraction, and tocopherol in enhancing colla-
gen synthesis and inhibiting collagen degradation in stress-
induced premature senescence model of human diploid
fibroblasts have been described. Skin aging can be intrinsic
or extrinsic, mediated genetically or due to environmental
exposures. Biodynes, tocotrienol-rich fraction, and toco-
pherol upregulate collagen genes and increase the synthesis
of procollagen proteins.
The AD is the outcome of a complex interaction among
several factors which are not fully understood yet; never-
theless, it is clear that oxidative stress and inflammatory
pathways are among these factors. In this special issue, lower
plasmatic levels of 𝛼-tocopherol and mild systemic oxidative
stress in the subclinical stage of Alzheimer’s disease have been
described.
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Also it has been described that sublethal oxidative stress
could induce premature senescence of human mesenchymal
stem cells derived from endometrium. Thus induction of
premature senescence might be a common physiological
response to sublethal oxidative stress in humanmesenchymal
stem cells of any origin.
Carbon monoxide (CO), an endogenous small gaseous
mediator, may exert important roles in physiological and
pathophysiological states through regulation of cellular sig-
naling pathways. It has been noted that CO when applied
at low concentration can confer anti-inflammatory effects in
macrophages and protect endothelial cells and hepatocytes
against cytotoxic agents.
The relationship between oxidative stress and aging by
addressing cellular expression profile analysis through pro-
teomics studies using two-dimensional electrophoresis and
mass spectrometry has been used as an integral approach to
study the aging process. Emphasis is placed on postmitotic
tissues, such as neuronal,muscular, and red blood cells, which
appear to be those most frequently studied with respect to
aging.
Ovarian aging-like phenotype in the hyperandrogenism-
induced murine model of polycystic ovary (PCO) is a new
topic. Exposure to some environmental factors and chemicals
during life may accelerate progression towards the end of
functional reproductive period. Hyperandrogenism-induced
PCO in rats is associated with ovarian aging-like phenotypes.
Meanwhile, hyperandrogenism triggers ovarian senescence
in rats with PCO.
Also in this special issue it was noted that increased
oxidative stress response in granulocytes from older patients
with a hip fracture may account for slow regeneration. Aged
granulocytes seem more sensitive towards damage induced
by oxidative stress rather than young granulocytes, declaring
why aged granulocytes cannot cope with the additional
oxidative stress stimuli of the fracture.
The production of ROS is not limited to a specific tissue
or organ and oxidative based damages to the cells can be
detected from the most superficial layer, skin, to different
internal compartments like nervous system, bone marrows
and hematopoietic system, liver, and the other parts of
endocrine system. Protective effects of antioxidative agents
like 𝛼-tocopherol and ascorbic acid in decreasing the rate
of senescence have been well studied, of course, mostly in
experimental models. However, effectiveness of modulators
of oxidative homeostasis in treatment of age-related diseases
still needs more studies along with opening more windows
from the interactions of oxidative elements in aging [3]. The
collection of data brought in this special issue is anticipated
to help researchers to resolve key questions about the role of
oxidative stress in aging and find promising perspectives on
the efficacy of oxidative modulating agents in treatment or
controlling age-related diseases.
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